Company Filing History:
Years Active: 2010-2019
Title: Innovations and Contributions of Debasis Patra
Introduction
Debasis Patra is a notable inventor based in Manlius, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of kinase modulation. With a total of 8 patents to his name, his work has the potential to impact various therapeutic applications.
Latest Patents
One of Debasis Patra's latest patents is titled "Compositions for modulating a kinase cascade and methods of use thereof." This invention relates to compositions that include 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide and its mesylate and dihydrochloride salts. The invention outlines an efficient process for synthesizing these compounds and methods for modulating components of a kinase cascade using the compositions. Additionally, the patent introduces a novel polymorph of the mesylate salt of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide (Form A), characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well as a distinct crystalline structure.
Career Highlights
Throughout his career, Debasis Patra has worked with several prominent companies in the pharmaceutical industry. Notable among these are Kinex Pharmaceuticals, LLC and Athenex, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Debasis has collaborated with several professionals in his field, including David G Hangauer, Jr and Jeremy A Cody. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Debasis Patra's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in kinase modulation, showcase the potential for advancements in therapeutic applications. His patents and collaborations reflect a commitment to improving healthcare through scientific discovery.